Camp4 Therapeutics (CAMP) Current Assets (2023 - 2026)

Camp4 Therapeutics has disclosed Current Assets across 4 years of filings, most recently posting $102.2 million for Q1 2026.

• Current Assets for Q1 2026 came in at $102.2 million, up 97.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.2 million (up 97.77% YoY), and the FY2025 annual result was $114.1 million, up 71.87% from the prior year.
• Current Assets came in at $102.2 million for Q1 2026 at Camp4 Therapeutics, down from $114.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $114.1 million in Q4 2025 to a low of $5.5 million in Q3 2024.
• The 4-year median for Current Assets is $59.0 million (2024), against an average of $62.3 million.
• Across the five-year window, Current Assets soared 65.9% in 2024 and jumped 1311.85% in 2025, its largest moves.
• Camp4 Therapeutics' Current Assets stood at $40.0 million in 2023, then jumped by 65.9% to $66.4 million in 2024, then jumped by 71.87% to $114.1 million in 2025, then fell by 10.43% to $102.2 million in 2026.
• The last three Current Assets figures came in at $102.2 million (Q1 2026), $114.1 million (Q4 2025), and $77.7 million (Q3 2025), per Business Quant data.